On this page
ZDHHC9
zDHHC palmitoyltransferase 9
ZDHHC9 is located on the long (q) arm of chromosome X, at band Xq26.1. Arm ratio per GRCh38 - banding schematic.
Explore chromosome X in the library →Available at Jeen Health
Clinical tests that include this
Overview
ZDHHC9 belongs to a family of enzymes that catalyse palmitoylation, the addition of palmitic acid (a 16-carbon fatty acid) to cysteine residues in target proteins. This post-translational modification is reversible and plays a critical role in regulating protein trafficking, stability, and interactions at cellular membranes. The gene is located on the X chromosome and has been implicated in neurodevelopmental conditions. Because ZDHHC9 resides on the X chromosome, pathogenic variants typically follow an X-linked pattern of inheritance, though the precise inheritance mode can vary depending on the specific variant and its functional consequences.
What the gene does
The ZDHHC9 protein functions as a palmitoyltransferase, catalysing the transfer of palmitate groups from palmitoyl-coenzyme A to substrate proteins. This enzymatic activity occurs primarily at intracellular membranes, where the enzyme modifies proteins involved in synaptic transmission and neuronal signalling. Palmitoylation by ZDHHC9 influences the membrane association of various neuronal proteins, affecting their ability to participate in cell-cell communication and intracellular signalling cascades. Research suggests that the enzyme shows particular importance in the developing and mature brain, where it helps regulate the localisation and function of proteins essential for cognitive processes. The reversible nature of palmitoylation allows cells to dynamically control protein behaviour in response to developmental cues and environmental signals.
Video: Genetics 101
Chromosome location
ZDHHC9 is located on the long arm of the X chromosome at position 26.1, designated as Xq26.1. This chromosomal region contains multiple genes, and its position on the X chromosome means that males (who carry only one X chromosome) and females (who carry two X chromosomes) may be affected differently by variants in this gene. The precise exon structure and transcript organisation have been characterised through genomic sequencing studies.
Protein structure
Domain architecture has not been experimentally characterised in detail for this protein. However, as a member of the DHHC palmitoyltransferase family, ZDHHC9 is predicted to contain a characteristic DHHC motif (aspartate-histidine-histidine-cysteine), which forms part of the catalytic centre responsible for the enzyme's palmitoyltransferase activity. The protein is thought to span cellular membranes multiple times, positioning the catalytic domain to interact with substrate proteins at membrane interfaces.
Key variants
Genetic variants in ZDHHC9 range from single nucleotide changes to larger deletions affecting the gene's coding sequence or regulatory regions. Because the gene is located on the X chromosome, the impact of a variant may differ between males and females, with males typically more severely affected when carrying a single pathogenic variant. The functional consequences of ZDHHC9 variants depend on their effect on enzyme activity and substrate specificity.
No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.
Associated conditions
Pathogenic variants in ZDHHC9 have been associated with X-linked intellectual disability, a condition characterised by cognitive impairment that runs in families following an X-linked inheritance pattern. Males carrying loss-of-function variants typically show more pronounced features, whilst females may exhibit milder manifestations or remain unaffected due to random X-inactivation. The neurodevelopmental impact reflects the enzyme's role in brain development and synaptic function, though the precise mechanisms linking reduced ZDHHC9 activity to cognitive outcomes remain an active area of research.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
UK clinical status
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What does the ZDHHC9 enzyme do in the body?
ZDHHC9 adds fatty acid molecules (palmitate) to specific proteins, particularly in the brain and nervous system. This modification helps control where proteins localise within cells and how effectively they carry out their functions in neuronal signalling and development.
Why does ZDHHC9 location on the X chromosome matter?
Because ZDHHC9 sits on the X chromosome, males (with one X) and females (with two X chromosomes) experience different effects from the same variant. Males typically show more severe features from pathogenic variants, whilst females may have milder or no symptoms due to having a second, functional copy of the gene.
How common are ZDHHC9 variants in the population?
The precise prevalence of ZDHHC9 variants in the general population has not been comprehensively established, though pathogenic variants appear to be rare. Population frequency data continue to be refined as large-scale genomic sequencing projects expand.